Author

Alessandro Sinopoli

ORCID 0009-0009-2484-3495Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Alessandro Sinopoli1 paper

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Alessandro Dell’AglioiD· 1 shared Amélie WiederkehriD· 1 shared Anna CamusiD· 1 shared Anna DevauxiD· 1 shared Anna HaydniD· 1 shared Christopher DivsalariD· 1 shared Clément LarrueiD· 1 shared Corinne EngdahliD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alessandro Dell’AglioORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringThe Journal of Experimental MedicinePeer-reviewedSep 9, 2023

Epitope Engineered Human Haematopoietic Stem Cells are Shielded from CD123-targeted Immunotherapy

Romina Marone, Emmanuelle Landmann, Anna Devaux…·Lukas T. Jeker

This paper shows that epitope-engineered human hematopoietic stem cells are protected from CD123-targeted immunotherapy while maintaining functionality, offering a strategy for tumor-selective therapy.

40 citationstop 3%

humanexperimental assay

𝕏 PostBluesky